Cautions for the wider drug class Class-level Approved GLP-1 medicines carry label warnings about pancreas inflammation, gallbladder problems, thyroid tumours seen in rodent studies, and low blood sugar when combined with insulin or sulfonylureas (a diabetes drug group)
*Trial figures are group averages from studies of the FDA-approved branded medications, not compounded preparations
Trustworthy Expertise You Can Rely On Our team, led by Dr
Always inject into fatty tissue, not muscle, for proper absorption and minimal discomfort
Mixes effortlessly with water or other beverages, consume throughout the day, before or during workout
\Trackable Results: Changes in certain blood markers, including IGF-1, can be used to monitor the effectiveness of CJC-1295